首页> 外文期刊>Acta Neurochirurgica >Clinical outcome following cerebral AVM hemorrhage
【24h】

Clinical outcome following cerebral AVM hemorrhage

机译:脑AVM出血后临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background A significant difference exists between the published results reporting the clinical outcome following brain arteriovenous malformation (AVM) ruptures. Information about the outcome following hemorrhage in an AVM population treated with radiosurgery could provide additional information to assess the risk of mortality and morbidity following an AVM hemorrhage. Methods Clinical outcome was studied in 383 patients, the largest patient population yet studied, who suffered from a symptomatic hemorrhage after Gamma Knife (R) surgery (GKS) but before confirmed AVM obliteration. The impact of different patient, AVM, and treatment parameters on the clinical outcome was analyzed. The aim was to generate outcome predictions by comparing our data to and combining them with earlier published results. Results No relation was found between clinical outcome and treatment parameters, indicating that the results are applicable also on untreated AVMs. Twenty-one percent of the patients died, 45% developed or experienced worsening of neurological sequelae, and 35% recovered completely after the hemorrhage. Old age was a predictor of poor outcome. Sex, AVM location, AVM volume, and history of prior hemorrhage did not influence the outcome. The mortality rate was comparable to earlier published prospective data, but higher than that found in retrospective studies. Conclusions The mortality rates in earlier published retrospective series as well as in studies focusing on clinical outcome following AVM hemorrhage significantly underestimate the risk for a mortal outcome following an AVM hemorrhage. Based on our findings, an AVM rupture has around 20% likelihood to result in mortality, 45% likelihood to result in a minor or major deficit, and 35% likelihood of complete recovery. The findings are probably applicable also for AVM ruptures in general. The cumulative mortality and morbidity rates 25 years after diagnosis were estimated to be around 40% in a patient with a patent AVM.
机译:背景技术在脑动静脉畸形(AVM)破裂后,公布结果与报告临床结果存在显着差异。有关用放射外科治疗的AVM人群出血后出现的结果可以提供额外的信息,以评估AVM出血后死亡率和发病率的风险。方法在383名患者中研究了临床结果,尚未研究过最大的患者人口,他患有伽马刀(R)手术(GKS)后患有症状出血,但在确认的AVM湮灭之前。分析了不同患者,AVM和治疗参数对临床结果的影响。目的是通过将我们的数据与早期公布的结果进行比较并将其组合来生成结果预测。结果在临床结果和治疗参数之间没有发现任何关系,表明结果也适用于未处理的AVM。二十一百分之二的患者死亡,45%发育或经历的神经系统后遗症恶化,出血后35%完全恢复。老年是一个糟糕的结果的预测因素。性别,AVM位置,AVM体积和现有出血的历史不会影响结果。死亡率与早期公布的预期数据相当,但高于在回顾性研究中的发现。结论早期发表的回顾性系列的死亡率以及在AVM出血后关注临床结果的研究显着低估了AVM出血后死亡结果的风险。根据我们的研究结果,AVM破裂有大约20%的可能性,导致死亡率,导致次要或重大赤字的可能性45%,以及完全恢复的可能性35%。这些结果也可能适用于一般的AVM破裂。诊断后25年的累积死亡率和发病率估计患者在患者中估计为50%,具有AVM的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号